Clinical Trial Update: Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients

View source ↗

Summary

A completed clinical trial update detailing the pharmacokinetics of low molecular weight heparin in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Cancer
• Thrombosis

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Cancer, Thrombosis | Status: COMPLETED